000120584 001__ 120584
000120584 005__ 20240228145454.0
000120584 0247_ $$2doi$$a10.1007/s10549-017-4141-8
000120584 0247_ $$2pmid$$apmid:28181128
000120584 0247_ $$2ISSN$$a0167-6806
000120584 0247_ $$2ISSN$$a1573-7217
000120584 0247_ $$2altmetric$$aaltmetric:16333250
000120584 037__ $$aDKFZ-2017-01013
000120584 041__ $$aeng
000120584 082__ $$a610
000120584 1001_ $$0P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aSteindorf, Karen$$b0$$eFirst author$$udkfz
000120584 245__ $$aEffects of exercise on sleep problems in breast cancer patients receiving radiotherapy: a randomized clinical trial.
000120584 260__ $$aDordrecht [u.a.]$$bSpringer Science + Business Media B.V.$$c2017
000120584 3367_ $$2DRIVER$$aarticle
000120584 3367_ $$2DataCite$$aOutput Types/Journal article
000120584 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1511253335_9899
000120584 3367_ $$2BibTeX$$aARTICLE
000120584 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000120584 3367_ $$00$$2EndNote$$aJournal Article
000120584 520__ $$aSleep problems frequently affect breast cancer patients during and after treatment and reduce their quality of life. Treatment strategies are mostly unknown. Thus, we assessed within a randomized controlled trial whether a 12-week exercise program starting with the radiotherapy influences sleep trajectories.Sleep quality and problems were assessed via self-report in 160 breast cancer patients before, during, and 2, 6, and 12 months after participation in a trial investigating resistance exercise versus a relaxation control group concomitant with radiotherapy. As additional comparison group, 25 age-matched healthy women exercised and followed identical study procedures. Ordinal logistic regression analyses were used.The exercise intervention significantly decreased sleep problems compared to the relaxation control group (scale: 0-100, with between-group mean differences of -10.2 (p = 0.03) from baseline to the end of radiotherapy and -10.9 (p = 0.005) to the end of the intervention), with sleep problems decreasing in the exercise group and increasing in the control group. At 12 months, differences were still observed but statistically non-significant (mean difference = -5.9, p = 0.20). Further adjustment for potential confounders did not change the results. Several determinants of sleep problems at baseline were identified, e.g., previous chemotherapy and higher body mass index.Our randomized exercise intervention trial confirmed results from earlier but mostly smaller studies that radiotherapy aggravates sleep problems in breast cancer patients and that exercise can ameliorate these effects. Considering that sleep quality can be a major predictor of quality of life, our findings are of substantial importance to many breast cancer patients.
000120584 536__ $$0G:(DE-HGF)POF3-317$$a317 - Translational cancer research (POF3-317)$$cPOF3-317$$fPOF III$$x0
000120584 588__ $$aDataset connected to CrossRef, PubMed,
000120584 7001_ $$0P:(DE-He78)60b584aeef81e4c57fd111fa63779b73$$aWiskemann, Joachim$$b1$$udkfz
000120584 7001_ $$aUlrich, Cornelia M$$b2
000120584 7001_ $$0P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac$$aSchmidt, Martina$$b3$$eLast author$$udkfz
000120584 773__ $$0PERI:(DE-600)2004077-5$$a10.1007/s10549-017-4141-8$$gVol. 162, no. 3, p. 489 - 499$$n3$$p489 - 499$$tBreast cancer research and treatment$$v162$$x1573-7217$$y2017
000120584 909CO $$ooai:inrepo02.dkfz.de:120584$$pVDB
000120584 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000120584 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)60b584aeef81e4c57fd111fa63779b73$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000120584 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000120584 9131_ $$0G:(DE-HGF)POF3-317$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vTranslational cancer research$$x0
000120584 9141_ $$y2017
000120584 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000120584 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBREAST CANCER RES TR : 2015
000120584 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000120584 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000120584 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000120584 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000120584 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000120584 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000120584 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000120584 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000120584 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000120584 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000120584 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000120584 9201_ $$0I:(DE-He78)G210-20160331$$kG210$$lBewegung, Präventionsforschung und Krebs$$x0
000120584 980__ $$ajournal
000120584 980__ $$aVDB
000120584 980__ $$aI:(DE-He78)G210-20160331
000120584 980__ $$aUNRESTRICTED